Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 21:54 UTC |
Manning Paul BDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,189 | $8.68 Strike: $10.44 | $18,991.76 |
DisclosureSEC source: 0001193125-26-412654 · ownership.xml · derivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,189 Underlying: Common Stock · 2,189 shares Expires 2036-09-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:56 UTC |
PAPA JOSEPH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,325 | $8.68 Strike: $10.44 | $11,495.70 |
DisclosureSEC source: 0001193125-26-412655 · ownership.xml · derivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,325 Underlying: Common Stock · 1,325 shares Expires 2036-09-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 21:57 UTC |
Loggia NicolettaDirector
|
GrantStock Option (Right to Buy) · Derivative | 380 | $8.68 Strike: $10.44 | $3,296.88 |
DisclosureSEC source: 0001193125-26-412658 · ownership.xml · derivative · entry 1 Loggia Nicoletta · CIK 0001979825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380 Underlying: Common Stock · 380 shares Expires 2036-09-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| September 11, 2026 Filed Sep 11, 2026 22:12 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 59,379 | $10.46 | $620,890.58 |
DisclosureSEC source: 0001873905-26-000002 · ownership.xml · nonDerivative · entry 3 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,321 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted on 3/13/2026 and modified on 6/11/2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $11.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 22:12 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001873905-26-000002 · ownership.xml · derivative · entry 4 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,638,968 Underlying: Common Stock · 125,000 shares Expires 2030-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted on 3/13/2026 and modified on 6/11/2026. F4 · derivative.exercise_date: 25% of this option vested and became exercisable on October 10, 2020, with another 25% vesting on September 14, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 22:12 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 220,866 | $11.50 | $2,539,892.74 |
DisclosureSEC source: 0001873905-26-000002 · ownership.xml · nonDerivative · entry 2 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,700 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted on 3/13/2026 and modified on 6/11/2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.20 to $12.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 22:12 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 125,000 | $1.55 | $193,750.00 |
DisclosureSEC source: 0001873905-26-000002 · ownership.xml · nonDerivative · entry 1 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 393,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 plan adopted on 3/13/2026 and modified on 6/11/2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:24 UTC |
Zimmermann MartineDirector
|
GrantStock Option (Right to Buy) · Derivative | 64,000 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0001193125-26-387924 · ownership.xml · derivative · entry 1 Zimmermann Martine · CIK 0001994049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2036-09-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in thirty-six (36) equal monthly installments, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:30 UTC |
Tyagarajan SeshuChief Technology Officer
|
SaleCommon Stock | 7,000 | $12.00 | $84,000.00 |
DisclosureSEC source: 0001923794-26-000004 · ownership.xml · nonDerivative · entry 1 Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,865 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:12 UTC |
Sims Mark E.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 285,000 | $0.00 Strike: $10.03 | $0.00 |
DisclosureSEC source: 0002139479-26-000004 · ownership.xml · derivative · entry 1 Sims Mark E. · CIK 0002139479 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,000 Underlying: Common Stock · 285,000 shares Expires 2036-07-06 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on July 6, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:21 UTC |
Manning Paul BDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,199 | $8.64 Strike: $10.30 | $18,997.16 |
DisclosureSEC source: 0001494695-26-000018 · ownership.xml · derivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,199 Underlying: Common Stock · 2,199 shares Expires 2036-06-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:20 UTC |
PAPA JOSEPH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,331 | $8.64 Strike: $10.30 | $11,498.51 |
DisclosureSEC source: 0001242215-26-000018 · ownership.xml · derivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,331 Underlying: Common Stock · 1,331 shares Expires 2036-06-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:20 UTC |
Loggia NicolettaDirector
|
GrantStock Option (Right to Buy) · Derivative | 381 | $8.64 Strike: $10.30 | $3,291.46 |
DisclosureSEC source: 0001979825-26-000006 · ownership.xml · derivative · entry 1 Loggia Nicoletta · CIK 0001979825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381 Underlying: Common Stock · 381 shares Expires 2036-06-30 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:22 UTC |
Barone FrancescaChief Scientific Officer
|
SaleCommon Stock | 23,447 | $10.06 | $235,768.96 |
DisclosureSEC source: 0001909680-26-000002 · ownership.xml · nonDerivative · entry 1 Barone Francesca · CIK 0001909680 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,362 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 20:22 UTC |
Tyagarajan SeshuChief Technology Officer
|
SaleCommon Stock | 7,000 | $10.02 | $70,151.20 |
DisclosureSEC source: 0001923794-26-000002 · ownership.xml · nonDerivative · entry 1 Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,865 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.07 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:36 UTC |
Radhakrishnan MahaDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0002013423-26-000004 · ownership.xml · derivative · entry 1 Radhakrishnan Maha · CIK 0002013423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:31 UTC |
Martell ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001873465-26-000002 · ownership.xml · derivative · entry 1 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:27 UTC |
Nguyen DiemDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001814338-26-000004 · ownership.xml · derivative · entry 1 Nguyen Diem · CIK 0001814338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:30 UTC |
Gaeta ReneeDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001742428-26-000004 · ownership.xml · derivative · entry 1 Gaeta Renee · CIK 0001742428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:32 UTC |
Benz Edward J. JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001691160-26-000002 · ownership.xml · derivative · entry 1 Benz Edward J. JR · CIK 0001691160 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:26 UTC |
Manning Paul BDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001494695-26-000015 · ownership.xml · derivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:33 UTC |
PAPA JOSEPH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001242215-26-000016 · ownership.xml · derivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:34 UTC |
Loggia NicolettaDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001979825-26-000004 · ownership.xml · derivative · entry 1 Loggia Nicoletta · CIK 0001979825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 20:28 UTC |
Nabel Gary J.Director
|
GrantStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001867450-26-000002 · ownership.xml · derivative · entry 1 Nabel Gary J. · CIK 0001867450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:17 UTC |
Manning Paul BDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,618 | $4.11 Strike: $4.90 | $18,998.45 |
DisclosureSEC source: 0001494695-26-000007 · ownership.xml · derivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,618 Underlying: Common Stock · 4,618 shares Expires 2036-03-31 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:10 UTC |
PAPA JOSEPH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,795 | $4.11 Strike: $4.90 | $11,498.63 |
DisclosureSEC source: 0001242215-26-000010 · ownership.xml · derivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,795 Underlying: Common Stock · 2,795 shares Expires 2036-03-31 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:08 UTC |
Loggia NicolettaDirector
|
GrantStock Option (Right to Buy) · Derivative | 779 | $4.11 Strike: $4.90 | $3,204.81 |
DisclosureSEC source: 0001979825-26-000002 · ownership.xml · derivative · entry 1 Loggia Nicoletta · CIK 0001979825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779 Underlying: Common Stock · 779 shares Expires 2036-03-31 F1 · derivative.exercise_date: This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant. Read SEC document |
| February 23, 2026 Filed Feb 27, 2026 00:38 UTC |
Manning Paul BDirector
|
PurchaseCommon Stock | 550,458 | $5.45 | $2,999,996.10 |
DisclosureSEC source: 0001193125-26-078246 · ownership.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 2,763,527 F1 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:00 UTC |
Barone FrancescaChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 232,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001193125-26-027392 · ownership.xml · derivative · entry 1 Barone Francesca · CIK 0001909680 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,000 Underlying: Common Stock · 232,000 shares Expires 2036-01-26 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 17:02 UTC |
Schoch CharlesChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 232,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001193125-26-027406 · ownership.xml · derivative · entry 1 Schoch Charles · CIK 0002007349 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,000 Underlying: Common Stock · 232,000 shares Expires 2036-01-26 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:04 UTC |
Tyagarajan SeshuChief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 154,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001193125-26-027412 · ownership.xml · derivative · entry 1 Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,000 Underlying: Common Stock · 154,000 shares Expires 2036-01-26 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 17:03 UTC |
Nichols William GarrettChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 136,500 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001193125-26-027409 · ownership.xml · derivative · entry 1 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,500 Underlying: Common Stock · 136,500 shares Expires 2036-01-26 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 22:01 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 629,000 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001193125-26-027396 · ownership.xml · derivative · entry 1 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 629,000 Underlying: Common Stock · 629,000 shares Expires 2036-01-26 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 937 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000950170-25-100320 · ownership.xml · derivative · entry 3 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,377 Underlying: Common Stock · 937 shares Expires 2033-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. F2 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
SaleCommon Stock | 937 | $6.98 | $6,540.26 |
DisclosureSEC source: 0000950170-25-100320 · ownership.xml · nonDerivative · entry 2 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,493 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 937 | $1.29 | $1,208.73 |
DisclosureSEC source: 0000950170-25-100320 · ownership.xml · nonDerivative · entry 1 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 781 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000950170-25-093035 · ownership.xml · derivative · entry 3 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,314 Underlying: Common Stock · 781 shares Expires 2033-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. F2 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
SaleCommon Stock | 781 | $5.04 | $3,936.24 |
DisclosureSEC source: 0000950170-25-093035 · ownership.xml · nonDerivative · entry 2 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,493 F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:30 UTC |
Nichols William GarrettChief Medical Officer
|
Exercise / conversionCommon Stock | 781 | $1.29 | $1,007.49 |
DisclosureSEC source: 0000950170-25-093035 · ownership.xml · nonDerivative · entry 1 Nichols William Garrett · CIK 0001618364 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Barone FrancescaChief Scientific Officer
|
GrantCommon Stock | 4,282 | $4.67 | $19,996.94 |
DisclosureSEC source: 0000950170-25-090194 · ownership.xml · nonDerivative · entry 1 Barone Francesca · CIK 0001909680 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,809 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 08:30 UTC |
Schoch CharlesChief Financial Officer
|
GrantCommon Stock | 5,353 | $4.67 | $24,998.51 |
DisclosureSEC source: 0000950170-25-090193 · ownership.xml · nonDerivative · entry 1 Schoch Charles · CIK 0002007349 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,391 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Tyagarajan SeshuChief Technology Officer
|
GrantCommon Stock | 5,353 | $4.67 | $24,998.51 |
DisclosureSEC source: 0000950170-25-090199 · ownership.xml · nonDerivative · entry 1 Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,865 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Martell ChristopherDirector
|
GrantCommon Stock | 111,349 | $4.67 | $519,999.83 |
DisclosureSEC source: 0000950170-25-090196 · ownership.xml · nonDerivative · entry 1 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 111,349 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. F2 · ownership.nature: Shares held by Spouse. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Manning Paul BDirector
|
GrantCommon Stock | 1,070,663 | $4.67 | $4,999,996.21 |
DisclosureSEC source: 0000950170-25-090197 · ownership.xml · nonDerivative · entry 1 Manning Paul B · CIK 0001494695 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Paul B. Manning Revocable Trust Disclosed balance after: 2,213,069 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. F2 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
PAPA JOSEPH CDirector
|
GrantCommon Stock | 64,239 | $4.67 | $299,996.13 |
DisclosureSEC source: 0000950170-25-090191 · ownership.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Joseph C. Papa Revocable Living Trust Disclosed balance after: 64,239 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. F2 · ownership.nature: Shares held by Joseph C. Papa Revocable Living Trust, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Loggia NicolettaDirector
|
GrantCommon Stock | 2,141 | $4.67 | $9,998.47 |
DisclosureSEC source: 0000950170-25-090195 · ownership.xml · nonDerivative · entry 1 Loggia Nicoletta · CIK 0001979825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,141 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Tak Paul PeterDirector · Chief Executive Officer
|
GrantCommon Stock | 42,826 | $4.67 | $199,997.42 |
DisclosureSEC source: 0000950170-25-090198 · ownership.xml · nonDerivative · entry 1 Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,566 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 12:30 UTC |
Nabel Gary J.Director
|
GrantCommon Stock | 5,353 | $4.67 | $24,998.51 |
DisclosureSEC source: 0000950170-25-090192 · ownership.xml · nonDerivative · entry 1 Nabel Gary J. · CIK 0001867450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,353 F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 16:30 UTC |
Schoch CharlesChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0000950170-25-089473 · ownership.xml · derivative · entry 1 Schoch Charles · CIK 0002007349 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-06-20 F1 · derivative.exercise_date: This option is subject to time-based vesting. 25% of the shares underlying this option shall vest and become exercisable on June 20, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 12:34 UTC |
Martell ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,240 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0000950170-25-087700 · ownership.xml · derivative · entry 1 Martell Christopher · CIK 0001873465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,240 Underlying: Common Stock · 14,240 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.